These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6368889)

  • 1. Prevention of Hemophilus influenzae type b disease.
    Band JD; Fraser DW; Ajello G
    JAMA; 1984 May; 251(18):2381-6. PubMed ID: 6368889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of rifampin in eliminating pharyngeal carriage of Haemophilus influenzae type b.
    Shapiro ED; Wald ER
    Pediatrics; 1980 Jul; 66(1):5-8. PubMed ID: 6967587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of rifampin and ampicillin in day care center contacts of Haemophilus influenzae type b disease.
    Gessert C; Granoff DM; Gilsdorf J
    Pediatrics; 1980 Jul; 66(1):1-4. PubMed ID: 6967580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of rifampin chemoprophylaxis on carriage eradication and new acquisition of Haemophilus influenzae type b in contacts.
    Glode MP; Daum RS; Boies EG; Ballard TL; Murray M; Granoff DM
    Pediatrics; 1985 Oct; 76(4):537-42. PubMed ID: 3900905
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rifampin chemoprophylaxis for household contacts of patients with invasive infections due to Haemophilus influenzae type b.
    Daum RS; Glode MP; Goldmann DA; Halsey N; Ambrosino D; Welborn C; Mather FJ; Willard JE; Sullivan B; Murray M; Johansen T
    J Pediatr; 1981 Mar; 98(3):485-91. PubMed ID: 7009819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampin alone and in combination with trimethoprim in chemoprophylaxis for infections due to Haemophilus influenzae type b.
    Glode MP; Daum RS; Halsey NA; Johansen TL; Goldmann DA; Ambrosino D; Boies E; Granoff DM
    Rev Infect Dis; 1983; 5 Suppl 3():S549-55. PubMed ID: 6605565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of subsequent disease among day-care contacts of patients with systemic Hemophilus influenzae type B disease.
    Murphy TV; Clements JF; Breedlove JA; Hansen EJ; Seibert GB
    N Engl J Med; 1987 Jan; 316(1):5-10. PubMed ID: 3491319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haemophilus influenzae type b infections in day care attendees: implications for management.
    Daum RS; Granoff DM; Gilsdorf J; Murphy T; Osterholm MT
    Rev Infect Dis; 1986; 8(4):558-67. PubMed ID: 3529311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rifampin prophylaxis v placebo for household contacts of children with Hemophilus influenzae type b disease.
    Murphy TV; Chrane DF; McCracken GH; Nelson JD
    Am J Dis Child; 1983 Jul; 137(7):627-32. PubMed ID: 6602542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampin for eradicating carriage of multiply resistant Haemophilus influenzae b.
    Campos J; Garcia-Tornel S; Roca J; Iriondo M
    Pediatr Infect Dis J; 1987 Aug; 6(8):719-21. PubMed ID: 3499591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasopharyngeal carriage of Haemophilus influenzae type b: attempted eradication by cefaclor or rifampin.
    Yogev R; Melick C; Kabat K
    Pediatrics; 1981 Mar; 67(3):430-3. PubMed ID: 6972517
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type B disease in a day care center: eradication of carrier state by rifampin.
    Granoff DM; Gilsdorf J; Gessert C; Basden M
    Pediatrics; 1979 Mar; 63(3):397-401. PubMed ID: 312483
    [No Abstract]   [Full Text] [Related]  

  • 13. Haemophilus influenzae type b in a nursery school: the value of biotyping.
    Prober CG; Ipp MM; Bannatyne RM
    Pediatrics; 1982 Feb; 69(2):215-8. PubMed ID: 6977129
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Haemophilus influenzae type b disease in an Amish population: studies of the effects of genetic factors, immunization, and rifampin prophylaxis on the course of an outbreak.
    Granoff DM; McKinney T; Boies EG; Steele NP; Oldfather J; Pandey JP; Suarez BK
    Pediatrics; 1986 Mar; 77(3):289-95. PubMed ID: 3485275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secondary Haemophilus influenzae type b in day-care facilities. Risk factors and prevention.
    Fleming DW; Leibenhaut MH; Albanes D; Cochi SL; Hightower AW; Makintubee S; Helgerson SD; Broome CV
    JAMA; 1985 Jul; 254(4):509-14. PubMed ID: 3874293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-benefit analysis of two strategies for prevention of Haemophilus influenzae type b infection.
    Hay JW; Daum RS
    Pediatrics; 1987 Sep; 80(3):319-29. PubMed ID: 3114708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rifampicin prophylaxis for throat carriage of Haemophilus influenzae type b in patients with invasive disease and their contacts.
    Gilbert GL; MacInnes SJ; Guise IA
    BMJ; 1991 Jun; 302(6790):1432-5. PubMed ID: 2070109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trimethoprim and rifampin in combination for chemoprophylaxis of household contacts of patients with invasive infections due to Haemophilus influenzae type b.
    Daum RS; Glode MP; Ambrosino D; Halsey N; Goldmann DA; Mather FJ; Russell R; Kamon J; Murray M; Band JD
    Antimicrob Agents Chemother; 1983 Nov; 24(5):658-62. PubMed ID: 6607027
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampin prophylaxis for contacts of Haemophilus influenzae type b disease.
    Cox F; Trincher R; Rissing JP; Patton M; McCracken GH; Granoff DM
    JAMA; 1981 Mar; 245(10):1043-5. PubMed ID: 6970272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of contacts of children in day care with invasive Haemophilus influenzae type b disease.
    Dashefsky B; Wald E; Li K
    Pediatrics; 1986 Nov; 78(5):939-41. PubMed ID: 3489921
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.